Diagnostic kits held laboratory reagents under CTH 3822 1990, Rule 1 GRI; no exemption due to BSA ingredient

The AAR held that the diagnostic kits imported by the applicant are "laboratory reagents" and are correctly classifiable under CTH 3822 1990 of the Customs Tariff Act, 1975, as "other kits," by application of Rule 1 of the General Rules for Interpretation. The materials do not qualify as "certified reference materials," and the department did not dispute the proposed classification; however, the revised classification will operate only prospectively. On exemption, the AAR ruled that the presence of Bovine Serum Albumin as one ingredient does not bring the composite diagnostic kits within Entry 102 read with List 3 of the relevant exemption notification, and the kits are therefore not eligible for Basic Customs Duty exemption.

---

---

1. ISSUES PRESENTED AND CONSIDERED

(1) Whether the diagnostic / laboratory kits in question are classifiable under tariff item 38221990 or under tariff item 38229090 of the First Schedule to the Customs Tariff Act, 1975.

(2) Whether the said kits, which contain Bovine Serum Albumin/Bovine Albumin as one of their constituents, are eligible for exemption from Basic Customs Duty under Entry 102 of Notification No. 45/2025-Customs dated 24.10.2025 read with Entry 9 of List 3 (earlier Entry 167(A) read with List 4 of Notification No. 50/2017-Customs).

2. ISSUE-WISE DETAILED ANALYSIS

Issue (1): Classification of the subject diagnostic / laboratory kits

Legal framework

(a) Tariff heading 3822 covers: "DIAGNOSTIC OR LABORATORY REAGENTS ON A BACKING, PREPARED DIAGNOSTIC OR LABORATORY REAGENTS WHETHER OR NOT ON A BACKING, WHETHER OR NOT PUT UP IN THE FORM OF KITS, OTHER THAN THOSE OF HEADING 3006; CERTIFIED REFERENCE MATERIALS."

(b) Within heading 3822, tariff item 38221990 is the residuary sub-heading for "Other" diagnostic or laboratory reagents on a backing / kits, while tariff item 38229090 is the residuary sub-heading under "Other" (i.e. goods other than "certified reference materials").

(c) Classification is governed by General Rules for the Interpretation of the Tariff, in particular Rule 1, which requires classification according to the terms of the headings and any relevant Section or Chapter Notes.

Interpretation and reasoning

(d) The subject goods (QIAstat-Dx Respiratory SARS-CoV-2 Panel; various artus HSV and CMV PCR kits; QIAscreen HPV PCR Test-RUO; Certal Residual DNA Detection Kit) are described and used as in vitro PCR-based diagnostic or laboratory kits containing reagents (including Bovine Serum Albumin) and enzymes for amplification, detection and quantification of nucleic acids. They are put up in the form of kits and are used for medical diagnosis or laboratory/research applications.

(e) On the basis of their description and use, the Court finds that these goods are "diagnostic or laboratory reagents ... put up in the form of kits" within the main text of heading 3822, and more particularly within the sub-structure "Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits."

(f) Applying Rule 1 of the General Interpretative Rules, since the goods are specifically covered as diagnostic or laboratory reagent kits, they fall squarely under sub-heading 3822.19 ("Other") and residuary item 38221990 ("--- Other"), being diagnostic / laboratory reagent kits not covered by the specific entries for malaria, Zika, Aedes-borne disease or blood-grouping, and not being "pregnancy test kits."

(g) The earlier self-classification by the applicant under 38229090 ("Other" under "Other") as "other reference material" is found to be erroneous. The Court notes that: (i) tariff item 38229010 specifically refers to "Certified reference material"; (ii) to qualify as such, materials must be accompanied by a certificate indicating the certified values, methods used, and degree of certainty for each value; and (iii) the subject goods are not so accompanied and do not have the attributes of "certified reference materials."

(h) Given that tariff item 38229090 is a generic residuary entry under the "Other" limb of heading 3822, and tariff item 38221990 is a more specific sub-entry for diagnostic / laboratory reagent kits, the more specific provision (38221990) must prevail over the generic residuary entry, in line with settled principles that residuary headings can be invoked only when the goods cannot reasonably be fitted into a specific heading.

(i) The Court further notes that there is no estoppel against correct classification in tax matters; a fresh and correct interpretation of the tariff can validly lead to change of an earlier erroneous classification, which will operate prospectively.

Conclusions

(j) The subject goods are diagnostic / laboratory reagents put up in the form of kits and are classifiable under tariff item 38221990 of the Customs Tariff Act, 1975.

(k) The earlier classification under tariff item 38229090 is held to be incorrect; change to 38221990 is legally permissible and takes effect prospectively.

Issue (2): Eligibility of the kits for exemption under Entry 102 of Notification No. 45/2025-Cus. read with Entry 9 of List 3 (Bovine Albumin)

Legal framework

(a) Entry 102 of Notification No. 45/2025-Customs grants exemption from the whole of customs duty to "lifesaving drugs/medicines including their salts and esters and diagnostic test kits specified in List 3" when classifiable under Chapters 28, 29, 30 or 38.

(b) Entry 9 of List 3 specifies "Bovine Albumin."

(c) The list structure indicates two broad categories: (i) named lifesaving drugs/medicines (including salts and esters) and (ii) fully and specifically identified diagnostic test kits (e.g. particular immunoassay kits, Pneumocystis carinii IF kits) expressly mentioned by name.

(d) Exemption notifications are to be construed strictly; the benefit is limited to goods clearly and specifically falling within the language of the exemption entry.

Interpretation and reasoning

(e) The applicant's claim rests on the presence of Bovine Serum Albumin (Bovine Albumin) as an ingredient in the kits, and the assertion that BSA is an "active" and critical component for the functioning of the diagnostic process (stabilising enzymes, preventing thermal degradation, binding impurities etc.).

(f) The Court observes that Entry 9 of List 3 refers only to "Bovine Albumin" simpliciter, and not to "diagnostic kits containing Bovine Albumin" or "reagents containing Bovine Albumin." It is a stand-alone entry for the substance itself, not for composite formulations in which it is one of several ingredients.

(g) The scheme of List 3 shows that:

(i) where the intention is to exempt a diagnostic kit, the kit itself is expressly and specifically named as such (e.g. specific immunoassay kits, Pneumocystis carinii IF kits); and

(ii) where a substance or component (e.g. Cobalt-60, Fibrinogen, Gallium Citrate, Bovine Albumin) is to be exempted, it is listed as a product by its own name, not as a constituent within another composite good.

(h) There is nothing in Notification No. 45/2025-Cus. indicating that a composite diagnostic kit or laboratory reagent becomes exempt merely because it contains, in any proportion, a substance separately listed in the exemption list. In the absence of explicit language to that effect, exemption cannot be extended to composite goods on an ingredient-based theory.

(i) The interpretive maxim expressio unius est exclusio alterius is attracted: because certain diagnostic kits are expressly named and exempted, those not so named are impliedly excluded from the benefit. The applicant's products are not individually or generically described as exempt diagnostic kits in List 3.

(j) The Court rejects the contention that the quantity or proportion of Bovine Albumin in the kit is irrelevant and that "mere presence" of BSA suffices. The entry does not cover "kits containing Bovine Albumin"; it covers only Bovine Albumin as a product. Extending exemption to any kit that contains BSA would amount to re-writing the notification.

(k) The reliance on the Inter Care decision (relating to agglutinating sera in pregnancy test kits) is distinguished. In that case, the kit essentially comprised agglutinating sera (the exempt product) reconstituted with buffer; the principal and active component, as such, was the exempt item itself. In the present matter, the goods are composite diagnostic kits made up of multiple reagents and constituents, with Bovine Serum Albumin only one among them. The factual and compositional matrix is thus materially different and the ratio of Inter Care is inapplicable.

Conclusions

(l) Entry 9 of List 3 under Notification No. 45/2025-Customs exempts only Bovine Albumin imported in its own right as an individual product; it does not extend to composite diagnostic kits or laboratory reagents which merely contain Bovine Albumin as an ingredient.

(m) The diagnostic / laboratory kits in question, though classifiable under Chapter 38 (tariff item 38221990) and containing Bovine Serum Albumin, are not specifically enumerated as diagnostic test kits in List 3 and therefore do not qualify for exemption under Entry 102 read with Entry 9 of List 3 of Notification No. 45/2025-Customs.

(n) The kits are consequently not eligible for exemption from Basic Customs Duty under the cited notification.

---